Immediate Loading of Implants in the Partially or Completely Edentulous Jaw (IMLOAD)

February 23, 2022 updated by: Johan Abeloos, AZ Sint-Jan AV
The investigators aim to evaluate the biological and mechanical short- and long-term outcome of IL in partially or completely edentulous patients. Moreover, the investigators aim to detect potential influencing risk factors predicting undesirable prosthetic outcome.

Study Overview

Status

Active, not recruiting

Detailed Description

Since its introduction in the late 1990s, immediate implant loading concepts (IL) have become a frequent alternative for delayed implant procedures. IL concepts reduce chair time, the number of surgical interventions and pain, and offer instant comfort to the patient. Its reduced treatment time results in obvious socioeconomic advantages. Although there is at present abundant evidence that supports IL, evaluation of long-term biological and mechanical stability outcomes of large patient populations could allow quality improvement and more accurate patient selection. The Departments of Oral and Maxillofacial Surgery and the Department of Dentistry of the General Hospital Saint-John Bruges act as one of the pioneers of IL in Belgium, routinely performing the concept since 2001.

The investigators aim to evaluate the biological and mechanical short- and long-term outcome of IL in partially or completely edentulous patients. Moreover, the investigators aim to detect potential influencing risk factors predicting undesirable prosthetic outcome.

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bruges, Belgium
        • General Hospital Saint-John Bruges

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients of all ages with loss of all or almost all teeth due to terminal periodontal disease and/or untreatable endodontic problems, that requested treatment according to the IL protocol between 01/01/2001 and 31/12/2015. Patients should have adequate bone volume to predominantly receive an implant of ≥13x3.5mm anteriorly and an implant of ≥9 x 3.5mm posteriorly. All patients, with or without a pre-prosthetic sinus floor augmentation, are included in de study.

Description

Inclusion Criteria:

  • patients of all ages
  • patients of all genders
  • patients with partially or complete edentulous jaw
  • patients treated at the department between 01/01/2001 and 31/12/2015

Exclusion Criteria:

  • patients not eligible according to abovementioned criteria
  • patients who required horizontal bone augmentation procedures of the complete alveolar bone
  • patients who required a jaw reconstruction after tumor resection, osteoradionecrosis or medication-related osteonecrosis of the jaw

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
implant survival rate
Time Frame: within 6 months post placement of implants
Percentage of people in the study for which implant is still present of the fixture in the oral cavity
within 6 months post placement of implants
implant survival rate
Time Frame: until a maximum of 15 years of follow-up
Percentage of people in the study for which implant is still present of the fixture in the oral cavity
until a maximum of 15 years of follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infection rate
Time Frame: within 6 months post placement of implants
Percentage of people in the study that develop an infection at the site of the implant in the oral cavity
within 6 months post placement of implants
Infection rate
Time Frame: until a maximum of 15 years of follow-up
Percentage of people in the study that develop an infection at the site of the implant in the oral cavity
until a maximum of 15 years of follow-up
correlation between patient-mediated factors and occurrence of implant instability
Time Frame: within 6 months post placement of implants
correlation between patient-mediated factors (age, gender, comorbidities, etc) and occurrence of implant instability, as clinically evaluated by the treating surgeon
within 6 months post placement of implants
correlation between patient-mediated factors and occurrence of implant instability
Time Frame: until a maximum of 15 years of follow-up
correlation between patient-mediated factors (age, gender, comorbidities, etc) and occurrence of implant instability, as clinically evaluated by the treating surgeon
until a maximum of 15 years of follow-up
correlation between clinical factors and the occurrence of implant instability
Time Frame: within 6 months post placement of implants
correlation between clinical factors (surgeon, surgical procedure, etc) as and the occurrence of implant instability, as clinically evaluated by the treating surgeon
within 6 months post placement of implants
correlation between clinical factors and the occurrence of implant instability
Time Frame: until a maximum of 15 years of follow-up
correlation between clinical factors (surgeon, surgical procedure, etc) as and the occurrence of implant instability, as clinically evaluated by the treating surgeon
until a maximum of 15 years of follow-up
correlation between implant characteristics and occurrence of implant instability
Time Frame: within 6 months post placement of implants
correlation between implant characteristics (design/finish/material) and occurrence of implant instability, as clinically evaluated by the treating surgeon
within 6 months post placement of implants
correlation between implant characteristics and occurrence of implant instability
Time Frame: until a maximum of 15 years of follow-up
correlation between implant characteristics (design/finish/material) and occurrence of implant instability, as clinically evaluated by the treating surgeon
until a maximum of 15 years of follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Johan Abeloos, MD, division of maxillofacial surgery, department of surgery, general hospital Saint-John Bruges

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2015

Primary Completion (ANTICIPATED)

December 1, 2030

Study Completion (ANTICIPATED)

December 1, 2031

Study Registration Dates

First Submitted

January 11, 2016

First Submitted That Met QC Criteria

January 19, 2016

First Posted (ESTIMATE)

January 22, 2016

Study Record Updates

Last Update Posted (ACTUAL)

February 28, 2022

Last Update Submitted That Met QC Criteria

February 23, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Jaw, Edentulous, Partially

3
Subscribe